UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations

Pain (Amsterdam), 2013-11, Vol.154 (11), p.2287-2296

2013

Volltextzugriff (PDF)

Evaluation of 5-HT7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice

Behavioural brain research, 2019-03, Vol.360, p.270-278

2019

Volltextzugriff (PDF)

Anxiety is functionally segregated within the septo-hippocampal system

Brain research, 2004-03, Vol.1001 (1), p.60-71

2004

Volltextzugriff (PDF)

Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents

European journal of pharmacology, 2006-12, Vol.551 (1-3), p.162-167

2006

Volltextzugriff (PDF)

CB1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action

Molecular pharmacology, 2006-10, Vol.70 (4), p.1236-1245

2006

Volltextzugriff (PDF)

Genetic deletion of muscarinic M4 receptors is anxiolytic in the shock-probe burying model

European journal of pharmacology, 2006-02, Vol.531 (1-3), p.183-186

2006

Volltextzugriff (PDF)

Biomarker-Guided Drug Development for Better Defined Early Patient Studies and Clinical Trial Efficiency

Handbook of Behavioral Neuroscience, 2019, Vol.29, p.17-23

2019

Volltextzugriff (PDF)

Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide

European journal of pharmacology, 2004-06, Vol.493 (1), p.103-109

2004

Volltextzugriff (PDF)

Genetic deletion of CB1 receptors improves non-associative learning

Behavioural brain research, 2005-07, Vol.162 (1), p.161-164

2005

Volltextzugriff (PDF)

Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests

Brain research, 2002-09, Vol.949 (1), p.60-70

2002

Volltextzugriff (PDF)

Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests

Pharmacology, biochemistry and behavior, 2001-07, Vol.69 (3), p.391-399

2001

Volltextzugriff (PDF)

Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test

The European journal of neuroscience, 2004-08, Vol.20 (4), p.1059-1064

2004

Volltextzugriff (PDF)

Evaluation of 5-HT 7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice

Behavioural brain research, 2018-12

2018

Volltextzugriff (PDF)

In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission

Current opinion in pharmacology, 2007-02, Vol.7 (1), p.62-68

2007

Volltextzugriff (PDF)

Genetic deletion of muscarinic M sub(4) receptors is anxiolytic in the shock-probe burying model

European journal of pharmacology, 2006-01, Vol.531 (1-3), p.183-186

2006

Volltextzugriff (PDF)

CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d -amphetamine: Role of mGlu5 receptors

European neuropsychopharmacology, 2009-03, Vol.19 (3), p.196-204

2009

Volltextzugriff (PDF)

Fluoxetine Disrupts the Integration of Anxiety and Aversive Memories

Neuropsychopharmacology (New York, N.Y.), 2005-02, Vol.30 (2), p.391-400

2005

Volltextzugriff (PDF)

Genetic deletion of muscarinic M 4 receptors is anxiolytic in the shock-probe burying model

European journal of pharmacology, 2006-02, Vol.531 (1), p.183-186

2006

Volltextzugriff (PDF)

Cannabinoid CB sub(1) receptor antagonism modulates plasma corticosterone in rodents

European journal of pharmacology, 2006-12, Vol.551 (1-3), p.162-167

2006

Volltextzugriff (PDF)

Infusions of physostigmine into the hippocampus or the entorhinal cortex attenuate avoidance retention deficits produced by intra-septal infusions of the GABA agonist muscimol

Brain research, 2001-11, Vol.920 (1), p.10-18

2001

Volltextzugriff (PDF)

Cannabinoid CB 1 receptor antagonism modulates plasma corticosterone in rodents

European journal of pharmacology, 2006, Vol.551 (1), p.162-167

2006

Volltextzugriff (PDF)

Increasing acetylcholine levels in the hippocampus or entorhinal cortex reverses the impairing effects of septal GABA receptor activation on spontaneous alternation

Learning & memory (Cold Spring Harbor, N.Y.), 2000-09, Vol.7 (5), p.293-302

2000

Volltextzugriff (PDF)

Acute exposure to a novel object during consolidation enhances cognition

Neuroreport, 2005-01, Vol.16 (1), p.63-67

2005

Volltextzugriff (PDF)

CB 1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action

Molecular pharmacology, 2006-10, Vol.70 (4), p.1236-1245

2006

Volltextzugriff (PDF)

CB sub(1) Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action

Molecular pharmacology, 2006-10, Vol.70 (4), p.1236-1245

2006

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Animals
(17)
Neurosciences
(15)
Male
(14)
Neurosciences & Neurology
(14)
Biological And Medical Sciences
(13)
Rats
(12)
Pharmacology & Pharmacy
(10)
Psychology. Psychoanalysis. Psychiatry
(9)
Fundamental And Applied Biological Sciences. Psychology
(8)
Hippocampus - Drug Effects
(7)
Medical Sciences
(7)
Rats, Sprague-Dawley
(7)
Acetylcholine - Metabolism
(6)
Anxiety
(6)
Hippocampus - Metabolism
(6)
Mice
(6)
Mice, Inbred C57bl
(6)
Mice, Knockout
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations

Evaluation of 5-HT7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice

Anxiety is functionally segregated within the septo-hippocampal system

Cannabinoid CB1 receptor antagonism modulates plasma corticosterone in rodents

CB1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action

Genetic deletion of muscarinic M4 receptors is anxiolytic in the shock-probe burying model

Biomarker-Guided Drug Development for Better Defined Early Patient Studies and Clinical Trial Efficiency

Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide

Genetic deletion of CB1 receptors improves non-associative learning

Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests

Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests

Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test

Evaluation of 5-HT 7 receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice

In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission

Genetic deletion of muscarinic M sub(4) receptors is anxiolytic in the shock-probe burying model

CB1 receptor knockout mice are hyporesponsive to the behavior-stimulating actions of d -amphetamine: Role of mGlu5 receptors

Fluoxetine Disrupts the Integration of Anxiety and Aversive Memories

Genetic deletion of muscarinic M 4 receptors is anxiolytic in the shock-probe burying model

Cannabinoid CB sub(1) receptor antagonism modulates plasma corticosterone in rodents

Infusions of physostigmine into the hippocampus or the entorhinal cortex attenuate avoidance retention deficits produced by intra-septal infusions of the GABA agonist muscimol

Cannabinoid CB 1 receptor antagonism modulates plasma corticosterone in rodents

Increasing acetylcholine levels in the hippocampus or entorhinal cortex reverses the impairing effects of septal GABA receptor activation on spontaneous alternation

Acute exposure to a novel object during consolidation enhances cognition

CB 1 Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action

CB sub(1) Receptor Antagonism Increases Hippocampal Acetylcholine Release: Site and Mechanism of Action

Suchergebnisse filtern